Our Events

Following on from the sell-out success of Cell & Gene Therapy Europe 2015, join Phacilitate at the second edition in Berlin in 2016. The premier event for Europe's cell and gene therapy community will offer attendees the opportunity to network, share best practice and learn from other leaders across the cell and gene therapy sector. Launching alongside Cell & Gene Therapy Europe will be Immunotherapy Europe 2016, so to find out how you can be part of this exciting, expanding event contact the Phacilitate team now on team@phacilitate.co.uk.

More info

Phacilitate are launching Immunotherapy Europe in Berlin in September 2016 alongside Cell & Gene Therapy Europe. Immuno-oncology is the hot topic across the life science sector following a slew of recent successes and approvals. Meet leaders from across the sector to discover the path to commercialization in Europe. Be part of this exciting new event from the start! To find out how contact Phacilitate on team@phacilitate.co.uk now.

More info

Big Data in Precision Medicine will be back in 2016 on 1-2 November! This executive level summit provides you the perfect opportunity to network with numerous senior-level drug development executives from pharma and biotech. Network and learn from: - The Big Data pioneers who are transforming the healthcare sector - An innovation auditorium looking at the critical, ground-breaking US health-care data applications - A critical review of how clinical-trial and healthcare system data is guiding R&D investment decisions

More info

From Promise to Products: Hear from 190+ leading speakers, meet 750+ key industry attendees and enjoy even more in-depth content next January.

More info

Latest News

Opinion Piece by Nigel Hughes

If health is to be reduced to the 0’s and 1’s of digitalisation, then the pharmaceutical industry needs to ensure it is a ‘1’ and not a ‘0’ in the rapidly evolving healthcare landscape.

More info

Opinion Piece by Nigel Hughes

Inside scoop on ASCO's CancerLinQ

A learning healthcare system would tell us how our testing and treatment plays out in the “real world” of oncology, a world far different than the highly regulated and structured world of clinical trials...

More info

Inside scoop on ASCO's CancerLinQ


Advisory Panel